Denali Therapeutics shares owned by Soleus Capital Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Soleus Capital Management
from 13F filings
Historical chart of Soleus Capital Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Soleus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.8M | 130k | 21.46 |